Investor Type | Firm |
Industries | BioTech • Life Science |
Investing | United States |
Investment Range | $93,000,000 - $93,000,000 |
ArrowMark Partners is an employee-owned asset management firm founded in 2007, based in Denver, Colorado, with a focus on niche and less efficient market segments across public and private credit and equity. They manage upwards of $12.5 billion in assets and emphasize a fundamental, research-driven investment philosophy. The firm seeks out asymmetric risk-reward opportunities in highly specialized and off-the-run areas of the capital markets, including alternative credit, growth equity asset classes, leveraged loans, and middle-market commercial real estate finance. ArrowMark aims to capitalize on their size and agility to uncover unique investment prospects that may be overlooked by larger institutions. With a mix of institutional clients and private wealth allocators, they offer a range of services - from managing broadly syndicated and middle-market CLO Funds to creating customized separately managed accounts. The firm's history showcases an organic expansion into synergistic market segments and strategies like launching multi-sector credit strategies, CLO platforms, and equity teams for small and mid-cap growth strategies. Further, they’ve engaged in regulatory capital relief transactions and established a commercial real estate lending platform. Their investment capabilities have extended with the launch of dedicated strategies in regulatory capital relief and life science cross-over, demonstrating adaptability and innovation in response to market opportunities and client needs. ArrowMark Partners is also active in securitized credit, with an expansion that includes a London office focusing on this area. Overall, ArrowMark Partners is dedicated to building enduring client partnerships by aligning their investment capabilities and client outcomes, continually adapting to evolving market conditions and client needs.